Newsroom | 2739 results

Sorted by: Latest

Veterinary
-

Dechra Advances Public Health as Newest Human-Animal Bond Certified Company

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Dechra, a global leader in veterinary specialty care, announced today its status as the newest Human-Animal Bond Certified Company....
-

PawDoc Surgery + Dental Center and Lakefield Veterinary Group Partner With Italian Greyhound Rescue Foundation to Provide Life-Changing Care for 20 Italian Greyhounds

KATY, Texas--(BUSINESS WIRE)--After being rescued from terrible living conditions in what officials called a suspected puppy mill and possible animal abuse case, more than 22 Italian Greyhounds are now beginning a new chapter filled with care, healing, and hope. After authorities seized over 40 dogs—many frightened, malnourished, and in need of urgent medical attention—the Italian Greyhound Rescue Foundation (IGRF) Texas and Oklahoma Chapter opened their arms to 22 of the dogs, determined to gi...
-

Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2025 and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended September 30, 2025 (compared to the three months ended September 30, 2024) Net sales of $363.9 million, an increase of $103.5 million, or 40% Net income of $26.5 million, an increase of $19.6 million Di...
-

Veterinary Monoclonal Antibodies Market Research Global Forecast Report 2025-2030: Opportunities in Expanding Therapeutic Indications, Novel Administration Routes, and Collaborations & Acquisitions - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Veterinary Monoclonal Antibodies Market by Animal Type, Product, Therapy Area, Route of Administration, and Region - Global Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. The global veterinary monoclonal antibodies market is projected to reach USD 3.06 billion by 2030, from USD 1.70 billion in 2025, with a CAGR of 12.4% The market is experiencing significant growth, driven by the expanding companion animal population and rising pet ow...
-

Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2025 fourth quarter ended September 30, 2025, revenue increased 5.9 percent to $83.7 billion. Revenue increased 9.3 percent to $321.3 billion for fiscal year 2025. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $(1.75) for the September quarter of fiscal 2025, compared to $0.02 in the prior year quarter. Adjusted diluted EPS, which is a...
-

VSAVA and NEL Animal Medical Foundation Partner to Introduce Vietnam's First Specialized Veterinary Cardiology Course

HO CHI MINH CITY, Vietnam--(BUSINESS WIRE)--VSAVA and NEL launch Vietnam’s first veterinary cardiology course, fostering Korea-Vietnam collaboration to advance Asian veterinary medicine....
-

Phibro Animal Health Corporation Declares Quarterly Dividend

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 17, 2025, to stockholders of record at the close of business on November 26, 2025. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner w...
-

Ankyra Announces Publication of Phase 1 Clinical Data, and Will Present at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored drug conjugate technology for cancer and other diseases, today announced the publication online of Part 1 results from its Phase 1 first-in-human study of tolododekin alfa in Nature Communications in the September 29, 2025, issue. Ankyra recently completed dose escalation of a phase 1 first-in-human study of monotherapy tolododekin alfa, the first anchored IL-12 designed for local...
-

Chewy Claus is Back to Spread Cheer, Grant Wishes, and Celebrate the Enduring Bonds Between Pets and Their People

PLANTATION, Fla.--(BUSINESS WIRE)--Chewy, Inc. (NYSE: CHWY) (“Chewy”) is once again unwrapping its annual letter-writing campaign, Chewy Claus, inspiring all pets (and their people) nationwide to dream big, give generously, and choose cuteness over naughtiness this holiday season. As always, Chewy Claus will be accepting holiday wish lists submitted via paws, claws, fins, wings, hooves, and any other letter-writing appendage. Since the program launched in 2022, more than one million pets have s...
-

Bond Vet Academy Draws Thousands of Veterinary Professionals Through Impactful Continuing-Education Events

NEW YORK--(BUSINESS WIRE)--Bond Vet, a leading provider of modern primary and urgent care for pets, continues to expand its commitment to veterinary education through Bond Vet Academy, a national series of continuing-education (CE) events and lectures designed to inspire and empower the veterinary community. Over the past year, more than 2,000 veterinary professionals have attended Bond Vet Academy CE events across the country — from intimate evening gatherings at Soho House to large-scale lect...